🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Study is To Evaluate the Efficacy and Safety of Anlotinib Hydrochlorid...
Status
Completed
Location
cancer hospital Chinese academy of medical sciences
Start Date
2021-01-01
Trial ID
NCT04671303
Treatments Being Tested
Evaluate the efficacy and safety of neoadjuvant furmonertinib combined with...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-10-01
Trial ID
NCT06585644
Treatments Being Tested
EGFR mutation-positive NSCLC patients have a higher risk of developing brai...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2025-04-02
Trial ID
NCT06945705
Treatments Being Tested
The goal of this clinical trial is to learn if furmonertinib plus anlotinib...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-07
Trial ID
NCT06483672
Treatments Being Tested
The aim of this phase Ⅱ study is to evaluate the efficacy and safety of Fur...
Status
Unknown
Location
Shanghai Chest Hospital
Start Date
2021-10-12
Trial ID
NCT04895930
Treatments Being Tested